245 related articles for article (PubMed ID: 32618586)
21. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.
Gutzmer R; Solomon JA
Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642
[TBL] [Abstract][Full Text] [Related]
22. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.
Jorgensen TJ; Ruczinski I; Yao Shugart Y; Wheless L; Berthier Schaad Y; Kessing B; Hoffman-Bolton J; Helzlsouer KJ; Kao WH; Francis L; Alani RM; Strickland PT; Smith MW; Alberg AJ
Cancer Epidemiol; 2012 Oct; 36(5):e288-93. PubMed ID: 22677152
[TBL] [Abstract][Full Text] [Related]
23. Alternative activation of hedgehog pathway induced by ultraviolet B radiation: preliminary study.
Lesiak A; Sobolewska-Sztychny D; Bednarski IA; Wódz K; Sobjanek M; Woźniacka A; Narbutt J
Clin Exp Dermatol; 2018 Jul; 43(5):518-524. PubMed ID: 29424103
[TBL] [Abstract][Full Text] [Related]
24. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
[TBL] [Abstract][Full Text] [Related]
25. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.
Tojo M; Mori T; Kiyosawa H; Honma Y; Tanno Y; Kanazawa KY; Yokoya S; Kaneko F; Wanaka A
Pathol Int; 1999 Aug; 49(8):687-94. PubMed ID: 10504535
[TBL] [Abstract][Full Text] [Related]
26. Basal cell carcinoma: pathophysiology.
Sehgal VN; Chatterjee K; Pandhi D; Khurana A
Skinmed; 2014; 12(3):176-81. PubMed ID: 25134314
[TBL] [Abstract][Full Text] [Related]
27. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
[TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinomas: attack of the hedgehog.
Epstein EH
Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog signaling in basal cell carcinoma.
Otsuka A; Levesque MP; Dummer R; Kabashima K
J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma.
Yin VT; Esmaeli B
Curr Pharm Des; 2017; 23(4):655-659. PubMed ID: 27928965
[TBL] [Abstract][Full Text] [Related]
32. Serum Vitamin D Levels Explored in the Latvian Cohort of Patients with Basal Cell Carcinoma Linked to the Sonic Hedgehog and Vitamin D Binding Protein Cutaneous Tissue Indices.
Moisejenko-Goluboviča J; Groma V; Svirskis Š; Ivanova A
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014865
[TBL] [Abstract][Full Text] [Related]
33. Advanced basal cell carcinoma: What dermatologists need to know about diagnosis.
Krakowski AC; Hafeez F; Westheim A; Pan EY; Wilson M
J Am Acad Dermatol; 2022 Jun; 86(6S):S1-S13. PubMed ID: 35577405
[TBL] [Abstract][Full Text] [Related]
34. MTOR promotes basal cell carcinoma growth through atypical PKC.
Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
[TBL] [Abstract][Full Text] [Related]
35. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
Danhof R; Lewis K; Brown M
Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
[TBL] [Abstract][Full Text] [Related]
36. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
Caro I; Low JA
Clin Cancer Res; 2010 Jul; 16(13):3335-9. PubMed ID: 20439455
[TBL] [Abstract][Full Text] [Related]
37. INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma.
Yang N; Leung EL; Liu C; Li L; Eguether T; Jun Yao XJ; Jones EC; Norris DA; Liu A; Clark RA; Roop DR; Pazour GJ; Shroyer KR; Chen J
Oncogene; 2017 Aug; 36(35):4997-5005. PubMed ID: 28459465
[TBL] [Abstract][Full Text] [Related]
38. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
39. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
